Healthfirst, a leading not-for-profit health plan serving more than two million New Yorkers, today announced the winners of its inaugural Pharmacy Excellence Awards, recognizing 12...
Orum Therapeutics (“Orum” or the “Company”) (KRX: 475830), a public biotechnology company pioneering the field of degrader-antibody conjugates (DACs), today announced the appointment of Dorin Toader,...
Veteran healthcare technology leader to drive revenue strategy and client growth Harmony Healthcare IT, a leading provider of health data management and archiving solutions, today...
Lubrizol announces new preclinical findings confirming the superior performance of its microencapsulated iron ingredient, Lipofer™ microcapsules, compared to conventional iron sources. The study, published in Nature,...
– New Data Showcase Safety Profile of Twice-Yearly Lenacapavir for Pre-Exposure Prophylaxis (PrEP) with Other Medications and Recruitment Strategies for PURPOSE 5 – – Five-Year BICSTaR Results...
Indivi and Clouds of Care, two independent TechBio companies, today announced a strategic partnership to advance the use of precision medicine tools in early-phase neuroscience...
Powered by the NC° Menopause Algorithm, the new app mode goes beyond symptom tracking to deliver science-backed, personalized insights for women navigating the menopausal transition...
Reimagined brand ecosystem will help independent ODs gain a deeper understanding of all thesolutions and support available in one membership IDOC, part of the world’s...
Pretty Good AI presents real-world clinical use cases and measurable results in operational automation. Pretty Good AI, the AI platform designed to scale healthcare practices,...
New digital innovation empowers patients to preview what their smile transformation could look like with the simple use of a smartphone or webcam ClearChoice Dental...
New START site at HM Montepríncipe University Hospital offers clinical trial access for children with cancer The START Center for Cancer Research (“START”), the world’s...
TransCode Therapeutics, Inc. (NASDAQ: RNAZ) announces completion of Phase 1a clinical trial with TTX-MC138, an investigational inhibitor of microRNA-10b, or miR-10b. By meeting its primary safety...
Trinity Capital Inc. (Nasdaq: TRIN) (the “Company”), a leading alternative asset manager, today announced the commitment of $130 million in growth capital to Candel Therapeutics, Inc. (Nasdaq: CADL) (“Candel”), a...
Achievement Follows Healthfirst’s #1 Quality Rating Among New York State Medicaid and Essential Plans Healthfirst, a leading not-for-profit health plan serving more than two million...
Launch of new healthcare plan for dual-eligible members of Medi-Cal and Medicare Enrollment begins October 15 This week CenCal Health announced the launch of CenCal CareConnect, a new...